Granatäppeljuice kan interagera med warfarin

Lakartidningen

Volumn 109, Issue 9-10, 2012, Pages 483-

  Andersson, Marine ^a   Lindh, Jonatan ^b  

^a Karolic ^*

^b Karolic   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

BEVERAGE; FOOD DRUG INTERACTION; FRUIT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LYTHRACEAE; NOTE;

ANTICOAGULANTS; BEVERAGES; FOOD-DRUG INTERACTIONS; FRUIT; HUMANS; INTERNATIONAL NORMALIZED RATIO; PUNICACEAE; WARFARIN;

EID: 84858209961     PISSN: 00237205     EISSN: 16527518     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Aviram M, Dornfeld L, Rosenblat M, et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000;71(5):1062-1076.
2. Mattiello T, Trifiro E, Jotti GS, et al. Effects of pomegranate juice and extract polyphenols on platelet function. J Med Food. 2009;12(2):334-339.
3. Nagata M, Hidaka M, Sekiya H, et al. Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. Drug Metab Dispos. 2007;35(2):302-305.
4. Komperda KE. Potential interaction between pomegranate juice and warfarin. Pharmacotherapy. 2009;29(8):1002-1006.
5. Jarvis S, Li C, Bogle RG. Possible interaction between pomegranate juice and warfarin. Emerg Med J. 2010;27(1):74-75.